GO:0001669; C:acrosomal vesicle; IEA:Ensembl
GO:0005887; C:integral component of plasma membrane; TAS:ProtInc
GO:0005886; C:plasma membrane; TAS:Reactome
GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:Reactome
GO:0004961; F:thromboxane A2 receptor activity; TAS:ProtInc
GO:0007596; P:blood coagulation; TAS:Reactome
GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
GO:0006954; P:inflammatory response; IEA:Ensembl
GO:0030168; P:platelet activation; TAS:Reactome
GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
GO:0043547; P:positive regulation of GTPase activity; TAS:GOC
GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl
GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
GO:0042493; P:response to drug; IEA:Ensembl
GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
GO:0007584; P:response to nutrient; IEA:Ensembl
GO:0019932; P:second-messenger-mediated signaling; IEA:Ensembl
GO:0038193; P:thromboxane A2 signaling pathway; TAS:GOC